a public good project by the
Synthesis
Company
of California

© 2026

Gregory A. Denomme | doi.page

0 works0 citations0 h-index

Gregory A. Denomme

Texas State University(US)Behavioral Diagnostics (United States)(US)Grifols (United States)(US)

Publications by Year

Research Areas

Blood groups and transfusion, Erythrocyte Function and Pathophysiology, Platelet Disorders and Treatments, Blood disorders and treatments, Hemoglobinopathies and Related Disorders

Most-Cited Works

→ Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4(1994)360 cited
→ It's time to phase inRHDgenotyping for patients with a serologic weakDphenotype(2014)194 cited
→ Immune-mediated thrombocytopenia of malaria.(1983)158 cited
→ High‐throughput multiplex single‐nucleotide polymorphism analysis for red cell and platelet antigen genotypes(2005)140 cited
→ A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry(1996)126 cited
→ Partial D, weak D types, and novelRHDalleles among 33,864 multiethnic patients: implications for anti‐D alloimmunization and prevention(2005)123 cited

→ International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings(2018)99 cited

→ Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia(1997)90 cited

→ Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura(2002)85 cited

→ International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings(2016)81 cited